Cargando…
Synthesis and molecular docking study of novel COVID-19 inhibitors
In 2020, the world tried to combat the corona virus (COVID-19) pandemic. A proven treatment method specific to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is still not found. In this study, seven new antiviral compounds were designed for COVID-19 treatment. The ability of these comp...
Autores principales: | GERÇEK, Zuhal, CEYHAN, Deniz, ERÇAĞ, Erol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326476/ https://www.ncbi.nlm.nih.gov/pubmed/34385863 http://dx.doi.org/10.3906/kim-2012-55 |
Ejemplares similares
-
Synthesis, characterized, QSAR studies and molecular docking of some phosphonates as COVID-19 inhibitors
por: Gholivand, Khodayar, et al.
Publicado: (2022) -
Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19
por: Alamshany, Zahra M., et al.
Publicado: (2023) -
Synthesis of novel coumarin–hydrazone hybrids as α-glucosidase inhibitors and their molecular docking studies
por: Tariq, Hafiza Zara, et al.
Publicado: (2023) -
Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors
por: Hawash, Mohammed, et al.
Publicado: (2023) -
Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors
por: Ahmed, Riham I., et al.
Publicado: (2016)